Crossmark

Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study

Crossref DOI link: https://doi.org/10.1038/s41409-024-02485-y

Published Online: 2024-12-02

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sun, Jie https://orcid.org/0000-0002-8568-6472
Zhang, Yi-Cheng

Wei, Jia https://orcid.org/0000-0002-6435-9368
Xu, Ya-Jing

Zhang, Yue

Li, Yu-Hua https://orcid.org/0000-0001-7174-0338
Wu, An-Qin

Fan, Lei

Zhu, Yu

Liu, Feng-Qi

Jiang, Zhong-Xing

Liu, Chao

Jiang, Ming

Qu, Jian-Hua

He, Peng-Cheng

Wang, Jie

Huang, Xiao-Bing https://orcid.org/0009-0001-2083-7663
Xiao, Rong

Gao, Su-Jun

Guo, Qiang

Wang, San-Bin

Li, Xiao-Ping

Fan, Sheng-Jin

Sun, Li-Li

Xu, Lan-Ping

Huang, Xiao-Jun

Zhang, Xiao-Hui https://orcid.org/0000-0003-4730-256X
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 24 September 2024

Revised: 18 November 2024

Accepted: 21 November 2024

First Online: 2 December 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below